Pegcetacoplan, a new treatment for macular degeneration – Science-Based Medicine
The context is analogous to a pair of drugs recently approved for Alzheimer’s disease. Aducanumab (Aduhelm) was FDA approved for treatment of …
The context is analogous to a pair of drugs recently approved for Alzheimer’s disease. Aducanumab (Aduhelm) was FDA approved for treatment of …
